{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T19:45:02Z","timestamp":1776023102702,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000837","name":"University of Nottingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejim.2026.106707","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:21:34Z","timestamp":1768076494000},"page":"106707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adrenal insufficiency following systemic glucocorticoid therapy: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4003-3678","authenticated-orcid":false,"given":"Jonathan","family":"Bowley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Shallish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Lax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2884-1998","authenticated-orcid":false,"given":"Fiona","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejim.2026.106707_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-020-0162-6","article-title":"A retrospective database study of oral corticosteroid and bisphosphonate prescribing patterns in England","volume":"30","author":"Chalitsios","year":"2020","journal-title":"NPJ Prim Care Respir Med"},{"issue":"7","key":"10.1016\/j.ejim.2026.106707_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-015905","article-title":"Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France","volume":"7","author":"B\u00e9nard-Laribi\u00e8re","year":"2017","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.ejim.2026.106707_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015237","article-title":"Systemic glucocorticoid use in Denmark: a population-based prevalence study","volume":"7","author":"Laugesen","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ejim.2026.106707_bib0004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cen.14114","article-title":"High prescription rate of oral glucocorticoids in children and adults: a retrospective cohort study from Western Sweden","volume":"92","author":"Einarsdottir","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.ejim.2026.106707_bib0005","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years","volume":"50","author":"Fardet","year":"2011","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.ejim.2026.106707_bib0006","first-page":"12","article-title":"Nationwide prevalence of glucocorticoid prescriptions over 17 years and osteoporosis prevention among long-term users","author":"Bjornsdottir","year":"2024","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.ejim.2026.106707_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123524","article-title":"From NSAIDs to glucocorticoids and beyond","volume":"10","author":"Sinniah","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.ejim.2026.106707_bib0008","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1210\/clinem\/dgae250","article-title":"European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency","volume":"109","author":"Beuschlein","year":"2024","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejim.2026.106707_bib0009","doi-asserted-by":"crossref","unstructured":"Arlt W., Allolio B. Adrenal insufficiency. Lancet. 2003;361(9372):1881\u201393. Available from: https:\/\/doi.org\/10.1016\/S0140-6736(03)13492-7.","DOI":"10.1016\/S0140-6736(03)13492-7"},{"issue":"10","key":"10.1016\/j.ejim.2026.106707_bib0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5694\/mja2.52140","article-title":"Glucocorticoid-induced adrenal suppression: physiological basis and strategies for glucocorticoid weaning","volume":"219","author":"Torpy","year":"2023","journal-title":"Med J Austr"},{"key":"10.1016\/j.ejim.2026.106707_bib0011","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3949\/ccjm.91a.23039","article-title":"Glucocorticoid-induced adrenal insuffi ciency and glucocorticoid withdrawal syndrome: two sides of the same coin","volume":"91","author":"Nachawi","year":"2024","journal-title":"Clevel Clin J Med"},{"key":"10.1016\/j.ejim.2026.106707_bib0012","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejim.2013.05.014","article-title":"Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself","volume":"24","author":"Dinsen","year":"2013","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.ejim.2026.106707_bib0013","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semarthrit.2016.03.001","article-title":"Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review","volume":"46","author":"Joseph","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ejim.2026.106707_bib0014","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"issue":"10","key":"10.1016\/j.ejim.2026.106707_bib0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.ejim.2026.106707_bib0017","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00535-024-02086-y","article-title":"Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis","volume":"59","author":"Hirayama","year":"2024","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ejim.2026.106707_bib0018","article-title":"Different oral corticosteroid regimens for acute asthma","volume":"2016","author":"Normansell","year":"2016"},{"key":"10.1016\/j.ejim.2026.106707_bib0019","first-page":"187","article-title":"Corticosteroids in the treatment of acute asthma","volume":"9","author":"Alangari","year":"2014"},{"issue":"4","key":"10.1016\/j.ejim.2026.106707_bib0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41584-020-0370-z","article-title":"Views on glucocorticoid therapy in rheumatology: the age of convergence","volume":"16","author":"Buttgereit","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ejim.2026.106707_bib0021","unstructured":"National Institute of Health and Care Excellence. https:\/\/cks.nice.org.uk\/topics\/corticosteroids-topical-skin-nose-eyes\/. 2024 [cited 2025 Mar 4]. Corticosteroids - topical (skin), nose, and eyes. Available from: https:\/\/cks.nice.org.uk\/topics\/corticosteroids-topical-skin-nose-eyes\/."},{"issue":"5","key":"10.1016\/j.ejim.2026.106707_bib0022","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/art.21747","article-title":"The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis","volume":"54","author":"Kirwan","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ejim.2026.106707_bib0023","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5414\/CPP40256","article-title":"A comparison of non-tapering vs. tapering prednisolone in acute exacerbation of asthma involving use of the low-dose ACTH test","volume":"40","author":"Karan","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ejim.2026.106707_bib0024","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.crohns.2009.09.007","article-title":"Clinical trial: preliminary efficacy and safety study of a new Budesonide-MMX R 9 mg extended-release tablets in patients with active left-sided ulcerative colitis","volume":"4","author":"D\u2019Haens","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.ejim.2026.106707_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000889","article-title":"Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study","volume":"5","author":"Buttgereit","year":"2019","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.ejim.2026.106707_bib0026","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10067-013-2374-4","article-title":"Intra-articular methylprednisolone acetate injection at the knee joint and the hypothalamic-pituitary-adrenal axis: a randomized controlled study","volume":"33","author":"Habib","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.ejim.2026.106707_bib0027","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jclinane.2013.07.002","article-title":"The effect of epidural methylprednisolone acetate injection on the hypothalamic-pituitary-adrenal axis","volume":"25","author":"Habib","year":"2013","journal-title":"J Clin Anesth"},{"issue":"4","key":"10.1016\/j.ejim.2026.106707_bib0028","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2015.01.037","article-title":"Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis","volume":"148","author":"Sandborn","year":"2015","journal-title":"Gastroenterology"},{"issue":"4S","key":"10.1016\/j.ejim.2026.106707_bib0029","first-page":"S283","article-title":"Relationship Between Epidural Steroid Dose and Suppression of Hypothalamus-Pituitary-Adrenal Axis","volume":"23","author":"Sim","year":"2020","journal-title":"Pain Physician"},{"issue":"4","key":"10.1016\/j.ejim.2026.106707_bib0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1440-1681.2000.03238.x","article-title":"Persson T. Treatment of joint pain in Crohn\u2019s patients with budesonide controlled ileal release","volume":"27","author":"Florin","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"10.1016\/j.ejim.2026.106707_bib0031","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.2008.03891.x","article-title":"Oral budesonide for maintenance of remission of Crohn\u2019s disease: a pooled safety analysis","volume":"29","author":"Lichtenstein","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ejim.2026.106707_bib0032","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.crohns.2012.06.006","article-title":"Efficacy and tolerability of oral budesonide in Japanese patients with active Crohn\u2019s disease: a multicentre, double-blind, randomized, parallel-group Phase II study","volume":"7","author":"Suzuki","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.ejim.2026.106707_bib0033","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/EJE-15-0182","article-title":"Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial","volume":"173","author":"Schuetz","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ejim.2026.106707_bib0034","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1365-2133.2001.04524.x","article-title":"Pituitary\u2013adrenal function following dexamethasone\u2013cyclophosphamide pulse therapy for pemphigus","volume":"145","author":"Kumrah","year":"2001","journal-title":"Brit J Dermatol"},{"issue":"7","key":"10.1016\/j.ejim.2026.106707_bib0035","article-title":"Assessment of Hypothalamic-Pituitary-Adrenal Axis Function After Corticosteroid Therapy in Inflammatory Bowel Disease","volume":"97","author":"Desram\u00e9","year":"2002","journal-title":"Off J Am Coll Gastroenterol | ACG"},{"issue":"4","key":"10.1016\/j.ejim.2026.106707_bib0036","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/EJE-17-0251","article-title":"Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis","volume":"177","author":"Borresen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"9203","key":"10.1016\/j.ejim.2026.106707_bib0037","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(99)06290-X","article-title":"Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment","volume":"355","author":"Henzen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2026.106707_bib0039","unstructured":"Imperial Centre for Endocrinology. https:\/\/www.impendo.co.uk\/prednisolone\/prednisolone-withdrawal. [cited 2025 Mar 25]. Imperial Centre for Endocrinology Prednisolone withdrawal. Available from: https:\/\/www.impendo.co.uk\/prednisolone\/prednisolone-withdrawal."},{"issue":"1","key":"10.1016\/j.ejim.2026.106707_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105285","article-title":"How to taper glucocorticoids in inflammatory rheumatic diseases? A narrative review of novel evidence in rheumatoid arthritis, systemic lupus erythematosus, and giant cell arteritis","volume":"89","author":"Buttgereit","year":"2022","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.ejim.2026.106707_bib0041","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4158\/EP-2017-0117","article-title":"Glucocorticoid-Induced Adrenal Insufficiency: a Study of the Incidence in Hospital Patients and A Review of Peri-Operative Management","volume":"24","author":"Rushworth","year":"2018","journal-title":"Endocr Pract"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T19:17:11Z","timestamp":1776021431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526000129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"alternative-id":["S0953620526000129"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106707","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenal insufficiency following systemic glucocorticoid therapy: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106707"}}